Breaking News

Real-time medication management technology

Aptar Pharma and Kali Care develop technology to address the challenge of monitoring adherence in ophthalmic clinical ...

Clinigen launches Japanese business to strengthen Asian presence

Clinigen is a global pharmaceutical and services company with a unique combination of businesses focused on providing ...

Bayer and DelSiTech link up to develop new ophthalmology drug delivery technology

Agreement highlights the potential of biodegradable silica material in demanding drug delivery applications

Vitreoretinal diseases Ė ocriplasmin

If the attachment between vitreous and the retina strengthens abnormally, it can threaten sight via conditions such as ...

Nicox to transfer commercial operations to new company led by GHO Capital

The deal values Nicox's operations at up to Ä26m

US FDA grants priority review for Nicox's AC-170 new drug application

FDA assigns Prescription Drug User Fee Act (PDUFA) goal date of 18 October 2016

Almac Discovery, McClay Foundation and Ulster University join forces to explore diseases of the eye

In a two-year project, the participants will investigate the effects of the protein FKBP-L on eye diseases

Regeneron and Bayer join forces to develop new combination therapy for eye diseases

Regeneron could potentially receive up to US$130m in upfront and milestone payments

Behcetís uveitis Ė gevokizumabn

BehÁetís disease causes severe non-infectious uveitis in about half of all patients and if not treated rapidly, can ...

Gene therapy pipeline has more than 900 products in active development

Early stage gene therapy pipeline is particularly strong, with 76% of products at either the discovery or preclinical ...

TxCell signs strategic agreement with MaSTherCell to manufacture cell therapy products

Company commits to an ambitious product development schedule with two discovery platforms